ICH: a2R1) VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY
ANVISA: CoLLEGIATE BOARD RESOLUTION – RDC No. 53, OF DECEMBER 4, 2015
ICH
NOT required
ANVISA
Required analysis cu 2+, Fe 3+(accelerate, oxidative reaction)
ICH
NOT clarify provided
ANVISA
Greater than 10 %
ICH
No clarity provided
ANVISA
executed
-Resolution of collegiate board RDC#166 of July 24,2017
ICH
No of liniarity solution
Minimum 5 concentration solution required
ANVISA
5 different concentration of CRS
Must be used for solution prepared.
Least triplicate
2.Evolution parameters
ICH
The correction coefficient, y intercept, slop of the regression line and residual sum of square should be submitted
ANVISA
Dispersion of the residual, coefficient of correction (r) and the determination (r2), angular coefficient, Homemoscedasticity,
ICH
No detail provided
ANVISA
The correction of coefficient should be above 0.990
The angular coefficient shall be significant different from zero.
Play remember all HPLC calibration link given below freeHeadline: Stop Memorizing HPLC SOPs. Start Mastering…
In pharmaceutical quality control, when a product fails the S1 stage of dissolution (like the…
product dimensions. For e-cigarettes, manufacturers would also need to provide specifications such as e-liquid volume,…
RCA (ROOT CAUSE ANALYSIS) IN PHARMACEUTICAL INDUSTRIES AS PER REGULATORY REQUIREMENTS 1. PROBLEM IDENTIFICATION What…
* Nitrosamines are trace chemical impurities. * They are classified as probable human carcinogens. *…
Specificity This concept is essential in scientific analysis. When you create a method to measure…